Transluminal Technologies Inc is categorized under Commercial Medical Research in Syracuse, NY and active since 2006.
Transluminal Technologies Inc was established in 2006, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 5413300 by the NAICS.
If you are seeking more information, feel free to contact Stephen Green, Owner at the company’s single location by writing to 2930 East Genesee St, Syracuse, New York NY 13224 or by phoning (315) 476-7510. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Transluminal Technologies Inc |
| Contact Person: | Stephen Green, Owner |
| Address: | 2930 East Genesee St, Syracuse, New York 13224 |
| Phone Number: | (315) 476-7510 |
| Website Address: | transluminal.net |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 2006 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 5413300 |
| Share This Business: |
Transluminal Technologies Inc was started in 2006 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 5413300. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Stephen Green, Owner for inquiries that concern Transluminal Technologies Inc by calling the company number (315) 476-7510, as your correspondence is most welcome. Additionally, the physical location of the single location of Transluminal Technologies Inc can be found at the coordinates 43.04226,-76.10264 as well as the street address 2930 East Genesee St in Syracuse, New York 13224.
For its online presence, you may visit Transluminal Technologies Inc’s website at transluminal.net and engage with its social media outlets through on Twitter and on Facebook.